Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRUE: Simethicone +/- NAC for Endoscopy Visibility
NCT01653171Phase 4Completed
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Jul 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of simethicone and acetylcysteine in gastric cancer (GC) (5 arms), sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: Visibility at upper endoscopy. Started Jul 2012; status: completed.
02
Drugs
simethiconeacetylcysteine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01653171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01653171.